NBIX
Price
$129.11
Change
-$0.29 (-0.22%)
Updated
Jul 3 closing price
Capitalization
13.72B
30 days until earnings call
TLRY
Price
$0.54
Change
+$0.05 (+10.20%)
Updated
Jul 3 closing price
Capitalization
1.87B
16 days until earnings call
Interact to see
Advertisement

NBIX vs TLRY

Header iconNBIX vs TLRY Comparison
Open Charts NBIX vs TLRYBanner chart's image
Neurocrine Biosciences
Price$129.11
Change-$0.29 (-0.22%)
Volume$387.39K
Capitalization13.72B
Tilray Brands
Price$0.54
Change+$0.05 (+10.20%)
Volume$43.04M
Capitalization1.87B
NBIX vs TLRY Comparison Chart in %
Loading...
NBIX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TLRY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NBIX vs. TLRY commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NBIX is a StrongBuy and TLRY is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 07, 2025
Stock price -- (NBIX: $129.11 vs. TLRY: $0.54)
Brand notoriety: NBIX: Not notable vs. TLRY: Notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: NBIX: 33% vs. TLRY: 169%
Market capitalization -- NBIX: $13.72B vs. TLRY: $1.87B
NBIX [@Pharmaceuticals: Other] is valued at $13.72B. TLRY’s [@Pharmaceuticals: Other] market capitalization is $1.87B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.8B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NBIX’s FA Score shows that 0 FA rating(s) are green whileTLRY’s FA Score has 0 green FA rating(s).

  • NBIX’s FA Score: 0 green, 5 red.
  • TLRY’s FA Score: 0 green, 5 red.
According to our system of comparison, NBIX is a better buy in the long-term than TLRY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NBIX’s TA Score shows that 3 TA indicator(s) are bullish while TLRY’s TA Score has 4 bullish TA indicator(s).

  • NBIX’s TA Score: 3 bullish, 5 bearish.
  • TLRY’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, TLRY is a better buy in the short-term than NBIX.

Price Growth

NBIX (@Pharmaceuticals: Other) experienced а +1.89% price change this week, while TLRY (@Pharmaceuticals: Other) price change was +30.63% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +2.13%. For the same industry, the average monthly price growth was +3.08%, and the average quarterly price growth was +93.03%.

Reported Earning Dates

NBIX is expected to report earnings on Nov 04, 2025.

TLRY is expected to report earnings on Oct 02, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+2.13% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NBIX($13.7B) has a higher market cap than TLRY($1.87B). NBIX has higher P/E ratio than TLRY: NBIX (57.20) vs TLRY (8.52). NBIX YTD gains are higher at: -5.414 vs. TLRY (-59.496). NBIX has higher annual earnings (EBITDA): 358M vs. TLRY (-1.23B). NBIX has more cash in the bank: 1.03B vs. TLRY (260M). NBIX has less debt than TLRY: NBIX (428M) vs TLRY (529M). NBIX has higher revenues than TLRY: NBIX (1.89B) vs TLRY (700M).
NBIXTLRYNBIX / TLRY
Capitalization13.7B1.87B735%
EBITDA358M-1.23B-29%
Gain YTD-5.414-59.4969%
P/E Ratio57.208.52672%
Revenue1.89B700M270%
Total Cash1.03B260M397%
Total Debt428M529M81%
FUNDAMENTALS RATINGS
NBIX vs TLRY: Fundamental Ratings
NBIX
TLRY
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
72
Overvalued
48
Fair valued
PROFIT vs RISK RATING
1..100
83100
SMR RATING
1..100
6096
PRICE GROWTH RATING
1..100
5063
P/E GROWTH RATING
1..100
3795
SEASONALITY SCORE
1..100
n/a85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TLRY's Valuation (48) in the Biotechnology industry is in the same range as NBIX (72). This means that TLRY’s stock grew similarly to NBIX’s over the last 12 months.

NBIX's Profit vs Risk Rating (83) in the Biotechnology industry is in the same range as TLRY (100). This means that NBIX’s stock grew similarly to TLRY’s over the last 12 months.

NBIX's SMR Rating (60) in the Biotechnology industry is somewhat better than the same rating for TLRY (96). This means that NBIX’s stock grew somewhat faster than TLRY’s over the last 12 months.

NBIX's Price Growth Rating (50) in the Biotechnology industry is in the same range as TLRY (63). This means that NBIX’s stock grew similarly to TLRY’s over the last 12 months.

NBIX's P/E Growth Rating (37) in the Biotechnology industry is somewhat better than the same rating for TLRY (95). This means that NBIX’s stock grew somewhat faster than TLRY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
NBIXTLRY
RSI
ODDS (%)
Bearish Trend 4 days ago
60%
Bearish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
56%
Bearish Trend 4 days ago
84%
Momentum
ODDS (%)
Bullish Trend 4 days ago
74%
Bullish Trend 4 days ago
85%
MACD
ODDS (%)
Bearish Trend 5 days ago
54%
Bullish Trend 4 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
70%
Bullish Trend 4 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
72%
Bullish Trend 4 days ago
80%
Advances
ODDS (%)
Bullish Trend 5 days ago
72%
Bullish Trend 4 days ago
81%
Declines
ODDS (%)
Bearish Trend 10 days ago
62%
Bearish Trend 14 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
79%
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
Bullish Trend 4 days ago
74%
Bearish Trend 4 days ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
NBIX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TLRY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
WBGSX9.230.11
+1.21%
William Blair Growth N
DGAGX40.610.31
+0.77%
BNY Mellon Appreciation Investor
DHFAX13.970.06
+0.43%
Diamond Hill Large Cap Concentrated Inv
VPACX15.730.03
+0.19%
Vanguard Pacific Stock Index Investor
TINGX26.010.01
+0.04%
Thornburg International Growth I

NBIX and

Correlation & Price change

A.I.dvisor tells us that NBIX and LFCR have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NBIX and LFCR's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NBIX
1D Price
Change %
NBIX100%
+0.87%
LFCR - NBIX
32%
Poorly correlated
N/A
EOLS - NBIX
30%
Poorly correlated
+0.65%
CGC - NBIX
29%
Poorly correlated
+7.56%
ELAN - NBIX
28%
Poorly correlated
-0.54%
TLRY - NBIX
27%
Poorly correlated
+11.03%
More